RCT

Published: Apr 2014

ACE Report #6335

Ace Report Cover

Early vs standard zoledronic acid treatments for prostate cancer metastatic to bone

Study Type:Therapy

OE Level Evidence:2

Journal Level of Evidence:N/A

Randomized Controlled Trial of Early Zoledronic Acid in Men With Castration-Sensitive Prostate Cancer and Bone Metastases: Results of CALGB 90202 (Alliance)

J Clin Oncol. 2014 Apr 10;32(11):1143-50. doi: 10.1200/JCO.2013.51.6500.

Contributing Authors: MR Smith S Halabi CJ Ryan A Hussain N Vogelzang W Stadler RJ Hauke JP Monk P Saylor N Bhoopalam F Saad B Sanford WK Kelly M Morris EJ Small

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Explore some of our unlocked reports below!

Treatment of osteoarthritis: A role for education programmes?

The prevalence of intimate partner violence in women presenting to orthopaedic clinics

Osteoporosis Choice decision aid improves treatment experience of clinicians and patients

Protein-Rich nutritional supplementation shows limited efficacy in elderly hip fractures

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.